Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +47.40%
#2 Pons Pons +35.27%
#3 Purr Purr +33.42%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.57%
#5 TENDIES TENDIES +28.48%
#6 Starpower Starpower +28.34%
#7 StonkBroker StonkBroker +23.34%
#8 SkyAI SkyAI +23.33%
#9 PondCoin PondCoin +22.89%
#10 Magma Finance Magma Finance +22.43%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Rang in aandelen #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Aandeelprijs
$152.40
Marktkapitalisatie
$376.40B
Verandering (1 dag)
12.48%
Verandering (1 jaar)
79.44%
Land
US
Handel Merck & Co., Inc. (MRK)

Categorie

Healthcare
P/B-ratio voor Merck & Co., Inc. (MRK)
P/B-ratio op August 2026 TTM: 8.01
Volgens de meest recente financiële rapporten en aandelenkoers van Merck & Co., Inc. is de huidige P/B-ratio (TTM) 8.01. Eind 2024 had het bedrijf een P/B-ratio van 5.44.
P/B-ratiohistoriek voor Merck & Co., Inc. van 2000 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
2026 (TTM) 8.01 57.64%
2025 5.08 -6.51%
2024 5.44 -28.09%
2023 7.56 23.82%
2022 6.11 20.29%
2021 5.08 -34.85%
2020 7.79 -9.22%
2019 8.59 21.37%
2018 7.07 67.90%
2017 4.21 9.48%
2016 3.85 22.74%
2015 3.14 -0.75%
2014 3.16 12.54%
2013 2.81 25.96%
2012 2.23 11.14%
2011 2.01 2.50%
2010 1.96 57.27%
2009 1.24 -62.32%
2008 3.30 -50.09%
2007 6.61 28.29%
2006 5.16 39.08%
2005 3.71 -5.78%
2004 3.93 -37.81%
2003 6.33 -5.53%
2002 6.70 -16.24%
2001 7.99 -42.42%
2000 13.88 0.00%
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 31.0864 288.19%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.4766 -6.64%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -74.4354 -1,029.51%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 8.4776 5.86%
CH
Novartis AG Novartis AG
Novartis AG
NOVN.SW
 6.754 -15.66%
CH